ACT

JANUARY 9/2018


news roundup

PAREXEL Announces Enhanced Global Data Operations

PAREXEL International Corporation introduced its Global Data Operations solution, with augmented processes and expertise that further bolsters its clinical data services, including data management, statistical programming, and biostatistics.


advertisment

Considerations for Efficient Site Contracts and Payments
Clinical trial agreement development has a tremendous impact on study start-up – integrating site-level budgets, payment terms, and Clinical Trial Management Systems set-up. By understanding the most important considerations for contract development and budget planning, you can execute a fully-integrated process that results in high-efficiency enabled contracts and payments.
Download the White Paper


Clinerion Joins HealthCarePoint's BlueCloud Patient Network

HealthCarePoints announced its mutual collaboration with Clinerion which will allow for both companies to fulfill their mission of transforming clinical trials by expanding access to patient data analytics services.


The Avoca Group Introduces Solution for Vendor Prequalification

The Avoca Group announced a new platform to accelerate the prequalification of clinical service providers by leveraging analytics-driven technology and industry standards to provide access to RFI questionnaires.


CTTI Selected to Support FDA Efforts to Increase Patient Engagement

CTTI is announcing it has been engaged by the FDA to support its Patient Engagement Collaborative. This collaborative aims at discussing ways in which patients can participate in the FDA's regulatory discussions about medical products.

advertisment

About Bridging Clinical Research & Clinical Health Care Collaborative
The Bridging Clinical Research & Clinical Health Care Collaborative will bring together leaders from pharma, biotech, clinical research organizations, health care organizations, advocacy groups and the FDA with the goal of doubling the number of physicians and patients involved in clinical research — from less than 3% up to 6%. Join us on April 4–5 in National Harbor, Md.
Register Today!


In this edition

CTTI Selected to Support FDA Efforts to Increase Patient Engagement
How to Minimize Subjectivity in Dermatology Data
Solving the Data Riddle to Yield Hope for Orphan Disease
Researchers Conduct NH Studies for Rare Diseases and Drug Development

advertisment

Speed, Efficiency and Accuracy in Site Contracts and Payments
Negotiating investigator site contracts and budgets, coupled with delivering global investigator payments, can be challenging. By coordinating services to work together cohesively, the clinical trial process can be streamlined. Download this Executive Summary for an expert discussion on expediting the delivery of global clinical trial contract negotiation.
Download Now


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

Clinical Data Disclosure and Transparency
EFGCP Annual Conference 2018
Clinical Trial Budgeting & Forecasting
Search Upcoming Events

Articles

Positive Changes for Clinical Trials in Ukraine

The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.


advertisment

Research Reveals a Need for Evolution in Randomization and Trial Supply Management (RTSM) Technology
Live Webcast: Wednesday, January 17 at 11am EST
Register now


How to Minimize Subjectivity in Dermatology Data

Until more sophisticated measures are created, a combination of investigator training and new imaging methods is the best way to create accurate, reproducible data across sites.

Blog Posts

Solving the Data Riddle to Yield Hope for Orphan Disease

This article will explore the issues with a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.


advertisment

The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
Register now


FDA Releases New Digital Health Draft Guidance Documents

In this interview, Austin Speier, VP of Emerging Technologies at Precision for Medicine, will elaborate on these draft guidance documents.


Oncology

TrialMax Touch® Selected for Pediatric Rare Disease Phase II Study

CRF Health has been selected by a specialty pharmaceutical company for its latest pediatric rare disease Phase II study. CRF Health's TrialMax Touch® handheld device alone with other solutions will be utilized to collect quality of life readings and alleviate the burden of data entry for caregivers.


advertisment

The Search for an HIV Vaccine: The Past, The Present and The Promise
On Demand
Learn more

 

Researchers Conduct NH Studies for Rare Diseases and Drug Development

Researchers use Natural History studies in order to examine rare diseases which will help facilitate drug development programs.


advertisment

The Clinical Trial of the Future is Here - Now: Understand how technology is transforming clinical development - now and in the future
On Demand
Learn more


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com